Table 1.
Full chemical name | Abbreviation | Log P |
Exposed functional groups |
Estimated consumption (ng/kg/day) |
References |
---|---|---|---|---|---|
2-amino-3-methylimidazo[4,5-f]quinoline | IQ | 1.5 | 1 Amine 1 Methyl | 0.23 – 0.28 | (Keating and Bogen, 2004; Layton et al., 1995; PubChem, 2017b) |
2-amino-3,4-dimethylimidazo[4,5-f]quinoline | MeIQ | 2.0 | 1 Amine 2 Methyl | ND | (PubChem, 2017c) |
2-amino-3,8-dimethylmidazo[4,5-f]quinoxaline | MeIQx | 1.0 | 1 Amine 2 Methyl | 1.10 – 2.61 | (Bogen and Keating, 2001; Keating and Bogen, 2004; Layton et al., 1995; PubChem, 2017d) |
2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline | 4,8-DiMeIQx | 1.4 | 1 Amine 3 Methyl | 0.20 – 0.81 | (Bogen and Keating, 2001; Keating and Bogen, 2004; PubChem, 2017g) |
2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine | PhIP | 2.2 | 1 Amine 1 Methyl | 6.00 – 16.64 | (Bogen and Keating, 2001; Keating and Bogen, 2004; Layton et al., 1995; PubChem, 2017a) |
1-methyl-9H-pyrido[3,4-b]indole | Harmane | 3.6 | 1 Methyl | NQ | (PubChem, 2017h) |
9H-Pyrido[3,4-B]indole | Norharmane | 3.2 | None | NQ | (PubChem, 2017f) |
2-amino-9H-pyrido[2,3-b]indole | AαC | 2.6 | 1 Hydrogen 1 Amine | 1.50 – 5.17 | (Bogen and Keating, 2001; Layton et al., 1995; PubChem, 2017e) |
ND: not detected, NQ: not quantified.